New 52 Week High Today

Regeneron Pharmaceuticals Inc REGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 02/03/23 EST

783.13UNCH (UNCH)

Volume

33,670

783.13

+31.93 (+4.25%)

Volume

1,412,755

52 week range

538.01 - 789.95

Open764.49
Day High789.95
Day Low758.63
Prev Close751.20
52 Week High789.95
52 Week High Date02/03/23
52 Week Low538.01
52 Week Low Date06/14/22

Key Stats

Market Cap85.284B
Shares Out108.90M
10 Day Average Volume0.62M
Dividend-
Dividend Yield-
Beta0.21
YTD % Change8.54

KEY STATS

Open764.49
Day High789.95
Day Low758.63
Prev Close751.20
52 Week High789.95
52 Week High Date02/03/23
52 Week Low538.01
52 Week Low Date06/14/22
Market Cap85.284B
Shares Out108.90M
10 Day Average Volume0.62M
Dividend-
Dividend Yield-
Beta0.21
YTD % Change8.54

RATIOS/PROFITABILITY

EPS (TTM)38.25
P/E (TTM)20.47
Fwd P/E (NTM)18.87
EBITDA (TTM)6.788B
ROE (TTM)27.76%
Revenue (TTM)13.71B
Gross Margin (TTM)85.39%
Net Margin (TTM)39.17%
Debt To Equity (MRQ)12.60%

EVENTS

Earnings Date05/02/2023(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Regeneron Pharmaceuticals Inc

Jim Cramer's top 10 things to watch in the market MondayJanuary 30, 2023CNBC.com
Monday's top analyst calls: Tesla, Apple, Netflix, Amazon, UPS, Meta, Shopify January 30, 2023CNBC.com
Cowen says buy Regeneron, success of drugs could help pharmaceutical stockJanuary 30, 2023CNBC.com
These stocks usually top Wall Street earnings estimates and rallyJanuary 29, 2023CNBC.com
Cramer’s week ahead: Fed decision on Wednesday could let the bulls ‘party on’January 27, 2023CNBC.com

Content From Our Affiliates

Regeneron announces new $3B share repurchase programFebruary 3, 2023TipRanks
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating ResultsFebruary 3, 2023TipRanks
Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03February 3, 2023TipRanks
Bank of America Securities Keeps Their Sell Rating on Regeneron (REGN)February 3, 2023TipRanks
Notable companies reporting before tomorrow’s openFebruary 2, 2023TipRanks

Profile

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA...

P. Roy Vagelos M.D.

Chairman of the Board

Leonard Schleifer M.D., Ph.D.

President, Chief Executive Officer, Founder, Director

George Yancopoulos M.D., Ph.D.

President, Chief Scientific Officer, Director

Robert Landry

Chief Financial Officer, Executive Vice President - Finance

Daniel Van Plew

Executive Vice President, General Manager - Industrial Operations and Product Supply

Address

777 Old Saw Mill River Road

Tarrytown, NY

10591</